Click Here to return To Results

 

Galcanezumab in Chronic Migraine Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018 See this aricle in Pubmed Article Abstract Both doses of galcanezumab were superior to placebo in reducing the number of monthly MHDs. Galcanezumab appears efficacious, safe, and well tolerated for the preventive treatment of chronic migraine.

Related Tags

(click to filter results - removes previous filter) calcitonin gene-related peptide receptor blocker efficacy galcanezumab migraine migraine,chronic migraine,prophylaxis migraine,treatment of monoclonal antibodies safety treatment of neurologic disorder

Click Here to return To Results